Junhao Luo

机构：Chinese Center For Disease Control and Prevention, National Institute for Viral Disease Control and Prevention, National Institute for Communicable Disease Control and Prevention · ORCID：0000-0003-0137-4365

发表论文 10 篇 · 总被引 31 次 · h-index 3

代表论文

• A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19 (2023 · International Journal of Molecular Sciences · 被引 16)
• The Development of a Novel Broad-Spectrum Influenza Polypeptide Vaccine Based on Multi-Epitope Tandem Sequences (2025 · Vaccines · 被引 4)
• Spleen tyrosine kinase inhibitor R406 has both antiviral and anti‐inflammatory effects on severe influenza A infection (2024 · Journal of Medical Virology · 被引 4)
• Deficiency of C-reactive protein or human C-reactive protein transgenic treatment aggravates influenza A infection in mice (2022 · Frontiers in Immunology · 被引 3)
• The critical role of RAGE in severe influenza infection: A target for control of inflammatory response in the disease (2024 · Clinical Immunology · 被引 2)
• The RAGE–Ferroptosis Axis Drives Oxidative Stress-Associated Inflammatory Lung Injury in Viral Infection (2026 · Antioxidants · 被引 1)